Bedminster, NJ, United States of America

Shelley Bower


Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 93(Granted Patents)


Location History:

  • Dagenham, GB (2004)
  • Bedminster, NJ (US) (2008)

Company Filing History:


Years Active: 2004-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Shelley Bower: Pioneering Substituted Azabicyclic Compounds

Introduction: Shelley Bower is an accomplished inventor based in Bedminster, NJ, with a focus on innovative pharmaceutical compounds. With a total of two patents to her name, she has made significant contributions to the field of medicinal chemistry.

Latest Patents: One of her latest patents is centered around substituted azabicyclic compounds. This invention is directed to physiologically active compounds defined by a specific formula where the compound includes a bicyclic ring system consisting of approximately 10 to 13 ring members. Notably, the ring features an azaheterocycle, while another aspect encompasses an azaheteroaryl ring or optionally halo-substituted benzene ring. The compounds exhibit the ability to inhibit the production or physiological effects of TNF and cyclic AMP phosphodiesterase. Furthermore, this patent also covers pharmaceutical compositions that utilize these compounds, discussing their pharmaceutical applications and methods for their preparation.

Career Highlights: Shelley works at Aventis Pharma Limited, a company dedicated to advancing health through innovative pharmaceutical solutions. Her expertise and inventive spirit have allowed her to develop effective compounds that can potentially transform therapeutic approaches in medicine.

Collaborations: Throughout her career, Shelley has collaborated with notable colleagues such as Paul Joseph Cox and David John Aldous. These partnerships not only enhance her work but also contribute to the overall innovation ecosystem within the pharmaceutical industry.

Conclusion: Shelley Bower's inventive contributions in the realm of substituted azabicyclic compounds exemplify the impactful work being done in medicinal chemistry. Her patents pave the way for future developments that may improve treatment options and health outcomes for many individuals. Through her career at Aventis Pharma Limited, she continues to embody the spirit of innovation that drives our understanding and capabilities in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…